share_log

Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Market Cap Surged CN¥2.3b Last Week, Private Companies Who Have a Lot Riding on the Company Were Rewarded

Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Market Cap Surged CN¥2.3b Last Week, Private Companies Who Have a Lot Riding on the Company Were Rewarded

凱萊英(臨時代碼)的市值上週暴漲了23億元人民幣,對該公司寄希望的私人企業也得到了回報。
Simply Wall St ·  08/02 20:59

Key Insights

主要見解

  • Asymchem Laboratories (Tianjin)'s significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public
  • 50% of the business is held by the top 7 shareholders
  • Institutions own 29% of Asymchem Laboratories (Tianjin)
  • 凱萊英(臨時代碼)的重要私人公司所有權表明,主要決策受到來自更大公衆的股東的影響
  • 前七大股東持有了該公司50%的股份。
  • 機構擁有凱萊英(臨時代碼)的29%股份

If you want to know who really controls Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821), then you'll have to look at the makeup of its share registry. We can see that private companies own the lion's share in the company with 35% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

如果您想知道誰真正控制凱萊英(臨時代碼)有限公司(SZSE:002821),那麼您需要看一下其股權登記簿的構成。我們可以看到,私人公司擁有該公司的絕大部分股權,佔35%。換句話說,該集團最有可能(或最有可能)從他們對公司的投資中獲得最多的收益。

As a result, private companies collectively scored the highest last week as the company hit CN¥25b market cap following a 9.7% gain in the stock.

因此,私人公司在上週得分最高,公司股價上漲9.7%,達到CN¥250億市值。

In the chart below, we zoom in on the different ownership groups of Asymchem Laboratories (Tianjin).

在下圖中,我們放大了凱萊英(臨時代碼)的不同所有權集團。

big
SZSE:002821 Ownership Breakdown August 3rd 2024
SZSE:002821所有權明細2024年8月3日

What Does The Institutional Ownership Tell Us About Asymchem Laboratories (Tianjin)?

機構持有凱萊英(臨時代碼)的股份告訴我們什麼?我們可以看到,凱萊英(臨時代碼)確實擁有機構投資者,並且他們持有公司的很大一部分股票。這意味着爲這些機構工作的分析師已經看過該股票並喜歡它。但是與其他任何人一樣,他們可能是錯誤的。當多個機構擁有股票時,存在它們處於「擁擠交易」中的風險。當這樣的交易出現問題時,多個方可能會競相快速出售股票。這種風險在一個沒有增長曆史的公司中更高。您可以在下面看到凱萊英(臨時代碼)的歷史收益和營業收入,但請記住,總會有更多的故事。

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與常見的指數回報進行比較。因此,他們通常會考慮購買包括在相關基準指數中的較大公司。

We can see that Asymchem Laboratories (Tianjin) does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Asymchem Laboratories (Tianjin)'s historic earnings and revenue below, but keep in mind there's always more to the story.

我們可以看到,凱萊英(臨時代碼)確實擁有機構投資者;他們持有公司的很大一部分股票。這意味着爲這些機構工作的分析師已經看過該股票並喜歡它。但是與其他任何人一樣,他們可能是錯誤的。當多個機構擁有股票時,存在它們處於「擁擠交易」中的風險。當這樣的交易出現問題時,多個方可能會競相快速出售股票。這種風險在一個沒有增長曆史的公司中更高。您可以在下面看到凱萊英(臨時代碼)的歷史收益和營業收入,但請記住,總會有更多的故事。

big
SZSE:002821 Earnings and Revenue Growth August 3rd 2024
SZSE:002821營收增長和收入增長2024年8月3日

We note that hedge funds don't have a meaningful investment in Asymchem Laboratories (Tianjin). Asymchem Laboratories, Inc. is currently the company's largest shareholder with 33% of shares outstanding. For context, the second largest shareholder holds about 5.9% of the shares outstanding, followed by an ownership of 4.1% by the third-largest shareholder. Hao Hong, who is the third-largest shareholder, also happens to hold the title of Chairman of the Board.

我們注意到,對於凱萊英(臨時代碼),對沖基金沒有意義的投資。目前,凱萊英(臨時代碼)的最大股東是凱萊英(Asymchem Laboratories, Inc.),持有33%的股份。爲了建立上下文,第二大股東持有約5.9%的股份,第三大股東擁有4.1%的股份。第三大股東是郝鴻,也是董事會主席。

We also observed that the top 7 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.

我們還觀察到,前7名股東擁有超過一半的股份登記冊,還有一些小股東來平衡較大股東的利益。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

儘管研究公司的機構持股可以增加您的研究價值,但研究分析師的建議也是一個好習慣,以更深入地了解股票的預期表現。有相當數量的分析師關注該股,因此了解他們對未來的總體觀點可能很有用。

Insider Ownership Of Asymchem Laboratories (Tianjin)

凱萊英(臨時代碼)的內部持股情況

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間有所不同。我們的數據反映了個人內部人員,至少捕捉到董事會成員的記錄。公司管理人員向董事會報告,後者應該代表股東的利益。值得注意的是,有時高級管理人員自己也在董事會中。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部所有權是積極的,因爲它可以表示董事會與其他股東的利益相一致。但是,在某些場合下,這個團體的權力過於集中。

We can report that insiders do own shares in Asymchem Laboratories (Tianjin) Co., Ltd.. It is a pretty big company, so it is generally a positive to see some potentially meaningful alignment. In this case, they own around CN¥1.1b worth of shares (at current prices). It is good to see this level of investment by insiders. You can check here to see if those insiders have been buying recently.

我們可以報告說,凱萊英(臨時代碼)的內部人員確實擁有股份。這是一家相當大的公司,因此看到一些潛在的重大調整是積極的。在這種情況下,他們擁有大約CN¥11億的股份(按當前價格計算)。看到內部人員進行了相當程度的投資是好的。您可以在此處檢查是否有內部人員最近購買。

General Public Ownership

一般大衆所有權

The general public, who are usually individual investors, hold a 31% stake in Asymchem Laboratories (Tianjin). This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

普通公衆,通常是個人投資者,持有凱萊英(臨時代碼)的31%股份。儘管這個持股規模相當可觀,但如果這種決定與其他大股東不符,則可能不足以改變公司政策。

Private Company Ownership

私有公司的所有權

It seems that Private Companies own 35%, of the Asymchem Laboratories (Tianjin) stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

看來,私人公司擁有凱萊英(臨時代碼)的股票,佔35%。更深入地了解一下這一點可能會有所幫助。如果相關方,例如內部人員,對其中一個私人公司擁有利益,那麼應在年度報告中披露這一點。私人公司也可能對公司有戰略利益。

Next Steps:

下一步:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 1 warning sign for Asymchem Laboratories (Tianjin) you should be aware of.

我發現看究竟誰擁有一家公司非常有趣。但是要真正獲得洞察力,我們需要考慮其他信息。典型情況是:我們已經發現凱萊英(臨時代碼)的1個警告標誌,您應該了解。

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

最終,未來最重要。您可以在這份關於該公司分析師預測的免費報告中獲取有關信息。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論